source
- Forge Biologics VP sees AI and Ohio talent driving next wave of gene therapy manufacturingSamantha Piteri-Molina, vice president of business and strategy at Forge Biologics, said her focus is on getting gene therapies into patients' hands. She helped steer Forge through a $620 million…
- Agios cuts over 35% of R&D staff as FDA decision on sickle cell drug is delayedAgios announced it will eliminate more than 100 R&D positions, representing over a third of its research staff, after the FDA postponed a decision on its sickle cell disease candidate. The company…